Please assess the completion status of the following clinical trial:

Trial Title: Orthotic Use for Chronic Low Back Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Males and females must be at least 18 years old.~2. Subjects must be symptomatic with current pain between T12 and the Sacroiliac joints with or without radiating pain.~3. Symptoms must have been present for at least three months.~Exclusion Criteria:~1. Use of custom-made shoe orthotics in the past year~2. Brain disorders (i.e.: dementia or Alzheimer's Disease) that would lead to difficulty in questionnaire completion.~3. Active conservative care (such as physical therapy or chiropractic care) for the low back received in the last six months (excluding the use of oral medications or daily at-home exercises for general well-being). We do not want to over-treat the patient or have any cross-over effects within this study from previous treatment.~4. Not fluent or literate in the English language. We will not be able to provide multiple translators within this pilot study.~5. Current or future litigation for low back pain.~6. Chronic pain other then low back pain such as fibromyalgia~7. Low back surgery in last six months.~8. Other conditions that may affect the outcomes of this study or exclude patients from participation in the study, including contraindications to orthotic use.~9. Peripheral neuropathy due to disorders such as diabetes.~10. Low back or leg pain that is not reproducible.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Orthotic group (Type: ACTIVE_COMPARATOR): Subjects are asked to wear custom-made shoe orthotics for a 12 week study period.
- Shoe Orthotic Wait group (Type: OTHER): The group serves as a cross-over control group. Subjects are asked to avoid any new therapies for the first 6 weeks of the 12 week study and during the last 6 weeks they are fitted for the custom-made shoe orthotics.

Based on this trial design, predict the completion outcome and termination type (if applicable).